|
IPA Statement Regarding the Management of Myozyme Supply - Advice to Patient Groups
|
IPA |
|
IPA Statement Regarding the Management of Myozyme Supply - Advice to Pompe Patients
|
IPA |
|
Myozyme Supply FAQs
|
IPA |
|
IMPORTANT MYOZYME SUPPLY INFORMATION HAS BEEN RELEASED (EU VERSION)
|
IPA |
|
IMPORTANT MYOZYME SUPPLY INFORMATION HAS BEEN RELEASED (GLOBAL VERSION)
|
IPA |
|
Pompe Program Update
|
Genzyme |
|
Pompe Program Update
|
Genzyme |
|
Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
|
Amicus |
|
Genzyme Provides Update on Myozyme® Manufacturing
|
Genzyme |
|
Pompe Program Update
|
Genzyme |
